TradingKey

关于 Teva Pharmaceutical Industries Ltd 公司

Teva Pharmaceutical Industries Ltd 是一家总部位于以色列的制药公司。该公司通过三个部门运营：北美、欧洲和国际市场。每个业务部门管理其所在地区的整个产品组合，包括仿制药、特种产品和非处方 (OTC) 产品。除了这三个部门之外，该公司还开展其他业务，主要是向第三方销售活性药物成分 (API)、某些合同制造服务以及通过其附属公司 Medis 向其他制药公司提供产品组合的对外授权平台。

公司简介

公司代码TEVA

公司名称Teva Pharmaceutical Industries Ltd

上市日期Jan 01, 1951

CEOMr. Richard D. Francis

员工数量33892

证券类型Ordinary Share

年结日Jan 01

公司地址124 Dvora Hanevi'a St.

城市TEL AVIV-YAFO

上市交易所Tel Aviv Stock Exchange

国家Israel

邮编6944020

电话97239148213

网址https://www.tevapharm.com/

公司代码TEVA

上市日期Jan 01, 1951

CEOMr. Richard D. Francis

公司高管

名称

名称/职务

职务

持股

持股变动

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Eliyahu Sharon (Eli) Kalif

Chief Financial Officer, Executive Vice President

--

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. Chen Lichtenstein

Independent Director

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

名称

名称/职务

职务

持股

持股变动

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Generic products

2.31B

59.26%

AUSTEDO

411.00M

10.56%

Anda

373.00M

9.59%

Other

220.00M

5.65%

AJOVY

139.00M

3.57%

Other

442.00M

11.36%

地区USD

名称

营收

占比

United States

1.91B

49.06%

Europe

1.19B

30.69%

International Markets

582.00M

14.96%

Other

205.00M

5.27%

业务

地区

业务USD

名称

营收

占比

Generic products

2.31B

59.26%

AUSTEDO

411.00M

10.56%

Anda

373.00M

9.59%

Other

220.00M

5.65%

AJOVY

139.00M

3.57%

Other

442.00M

11.36%

股东统计

更新时间: 7月12日周六

持股股东

股东类型

持股股东

占比

Fidelity Management & Research Company LLC

6.56%

Menora Mivtachim Insurance Ltd.

5.00%

Ion Asset Management Israel Ltd

3.40%

Clal Insurance Enterprises Holdings Ltd.

3.29%

Phoenix Investment and Finances Ltd

3.29%

Other

78.44%

持股股东

占比

Fidelity Management & Research Company LLC

6.56%

Menora Mivtachim Insurance Ltd.

5.00%

Ion Asset Management Israel Ltd

3.40%

Clal Insurance Enterprises Holdings Ltd.

3.29%

Phoenix Investment and Finances Ltd

3.29%

Other

78.44%

股东类型

持股股东

占比

Investment Advisor

27.60%

Hedge Fund

13.28%

Investment Advisor/Hedge Fund

11.76%

Insurance Company

7.31%

Research Firm

2.85%

Pension Fund

1.82%

Family Office

1.32%

Bank and Trust

0.82%

Sovereign Wealth Fund

0.22%

Other

33.01%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

1097

737.27M

64.27%

-2.94M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

2023Q2

921

512.98M

45.79%

-122.32M

2023Q1

927

576.84M

51.93%

-50.26M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Fidelity Management & Research Company LLC

75.30M

6.57%

-710.45K

-0.93%

Mar 31, 2025

Menora Mivtachim Insurance Ltd.

29.19M

2.55%

+808.07K

+2.85%

Mar 31, 2025

Ion Asset Management Israel Ltd

39.03M

3.4%

+2.38M

+6.50%

Mar 31, 2025

Clal Insurance Enterprises Holdings Ltd.

37.79M

3.3%

-1.17M

-3.00%

Mar 31, 2025

Phoenix Investment and Finances Ltd

27.46M

2.39%

+6.25M

+29.47%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

33.06M

2.88%

-39.31K

-0.12%

Mar 31, 2025

Lingotto Investment Management LLP

27.85M

2.43%

+661.55K

+2.43%

Mar 31, 2025

Migdal Insurance and Financial Holdings Ltd

26.34M

2.3%

+300.00K

+1.15%

Mar 31, 2025

Rubric Capital Management LP

25.55M

2.23%

+8.55M

+50.29%

Mar 31, 2025

Harel Insurance Investments and Financial Services Ltd

22.06M

1.92%

+22.04M

+197885.16%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

VanEck Israel ETF

6.53%

iShares MSCI Israel ETF

6.2%

Amplify Weight Loss Drug & Treatment ETF

5.06%

Tema Neuroscience and Mental Health ETF

4.99%

ARK Israel Innovative Technology ETF

1.74%

VanEck Pharmaceutical ETF

1.6%

WisdomTree International Multifactor Fund

0.55%

iShares Health Innovation Active ETF

0.49%

iShares MSCI Intl Value Factor ETF

0.4%

Fidelity New Millennium ETF

0.2%

VanEck Israel ETF

占比6.53%

iShares MSCI Israel ETF

占比6.2%

Amplify Weight Loss Drug & Treatment ETF

占比5.06%

Tema Neuroscience and Mental Health ETF

占比4.99%

ARK Israel Innovative Technology ETF

占比1.74%

VanEck Pharmaceutical ETF

占比1.6%

WisdomTree International Multifactor Fund

占比0.55%

iShares Health Innovation Active ETF

占比0.49%

iShares MSCI Intl Value Factor ETF

占比0.4%

Fidelity New Millennium ETF

占比0.2%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Teva Pharmaceutical Industries Ltd

15.650USD

Teva Pharmaceutical Industries Ltd

15.650

概览

公司

财务